

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular potassium ion homeostasis (GO:0030007) | 4.28910251 |
| 2 | surfactant homeostasis (GO:0043129) | 4.27174979 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.22000125 |
| 4 | sodium ion export (GO:0071436) | 4.21065428 |
| 5 | sulfate transmembrane transport (GO:1902358) | 4.04593165 |
| 6 | locomotory exploration behavior (GO:0035641) | 3.95657524 |
| 7 | synaptic vesicle maturation (GO:0016188) | 3.88862724 |
| 8 | cGMP-mediated signaling (GO:0019934) | 3.88065916 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.75470391 |
| 10 | vocalization behavior (GO:0071625) | 3.70964852 |
| 11 | glutamate secretion (GO:0014047) | 3.69099202 |
| 12 | chemical homeostasis within a tissue (GO:0048875) | 3.64035120 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.60726123 |
| 14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.55209534 |
| 15 | proline transport (GO:0015824) | 3.52635302 |
| 16 | sulfate transport (GO:0008272) | 3.41181966 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.41076879 |
| 18 | cellular sodium ion homeostasis (GO:0006883) | 3.40949480 |
| 19 | sperm capacitation (GO:0048240) | 3.39577418 |
| 20 | glomerular filtration (GO:0003094) | 3.32365782 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 3.26243617 |
| 22 | positive regulation of respiratory burst (GO:0060267) | 3.23077777 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 3.22845684 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.21511334 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.21317011 |
| 26 | ethanol oxidation (GO:0006069) | 3.18430873 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 3.10138634 |
| 28 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.08553990 |
| 29 | glycine transport (GO:0015816) | 3.08153247 |
| 30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.07260142 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.05313173 |
| 32 | renal filtration (GO:0097205) | 3.03800323 |
| 33 | regulation of ARF protein signal transduction (GO:0032012) | 3.02205483 |
| 34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.01978156 |
| 35 | potassium ion import (GO:0010107) | 3.00992365 |
| 36 | macroautophagy (GO:0016236) | 2.98849714 |
| 37 | cell communication by electrical coupling (GO:0010644) | 2.97471321 |
| 38 | regulation of guanylate cyclase activity (GO:0031282) | 2.97048738 |
| 39 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.95149939 |
| 40 | neurotransmitter secretion (GO:0007269) | 2.89428450 |
| 41 | regulation of synaptic vesicle transport (GO:1902803) | 2.86256857 |
| 42 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.85714990 |
| 43 | exploration behavior (GO:0035640) | 2.85590806 |
| 44 | renal system process involved in regulation of blood volume (GO:0001977) | 2.85069104 |
| 45 | long-term memory (GO:0007616) | 2.83982419 |
| 46 | potassium ion homeostasis (GO:0055075) | 2.78844282 |
| 47 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.76591739 |
| 48 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.75236371 |
| 49 | postsynaptic membrane organization (GO:0001941) | 2.74448974 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.74027843 |
| 51 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.73876961 |
| 52 | signal complex assembly (GO:0007172) | 2.72796582 |
| 53 | activation of protein kinase A activity (GO:0034199) | 2.72059283 |
| 54 | receptor recycling (GO:0001881) | 2.69907479 |
| 55 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.68833466 |
| 56 | transcytosis (GO:0045056) | 2.68713570 |
| 57 | axon ensheathment in central nervous system (GO:0032291) | 2.66784831 |
| 58 | central nervous system myelination (GO:0022010) | 2.66784831 |
| 59 | neuron-neuron synaptic transmission (GO:0007270) | 2.64673379 |
| 60 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.63527191 |
| 61 | neuronal action potential propagation (GO:0019227) | 2.63031032 |
| 62 | cellular glucuronidation (GO:0052695) | 2.61508898 |
| 63 | activation of MAPKKK activity (GO:0000185) | 2.61155322 |
| 64 | cell communication involved in cardiac conduction (GO:0086065) | 2.59709449 |
| 65 | membrane repolarization (GO:0086009) | 2.58134496 |
| 66 | bicarbonate transport (GO:0015701) | 2.57949696 |
| 67 | membrane hyperpolarization (GO:0060081) | 2.57013335 |
| 68 | nerve growth factor signaling pathway (GO:0038180) | 2.55437112 |
| 69 | presynaptic membrane assembly (GO:0097105) | 2.53885317 |
| 70 | regulation of protein glycosylation (GO:0060049) | 2.52265961 |
| 71 | negative regulation of myotube differentiation (GO:0010832) | 2.51868032 |
| 72 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.51425517 |
| 73 | cellular response to nitric oxide (GO:0071732) | 2.50509950 |
| 74 | ethanol metabolic process (GO:0006067) | 2.49825019 |
| 75 | neurotransmitter transport (GO:0006836) | 2.49723993 |
| 76 | gamma-aminobutyric acid transport (GO:0015812) | 2.48956288 |
| 77 | membrane repolarization during action potential (GO:0086011) | 2.48723751 |
| 78 | amino acid import (GO:0043090) | 2.47802394 |
| 79 | phosphate ion transmembrane transport (GO:0035435) | 2.47369597 |
| 80 | L-amino acid import (GO:0043092) | 2.46497044 |
| 81 | O-glycan processing (GO:0016266) | 2.46465829 |
| 82 | protein localization to synapse (GO:0035418) | 2.46377292 |
| 83 | cellular response to reactive nitrogen species (GO:1902170) | 2.45649280 |
| 84 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.45580554 |
| 85 | glucocorticoid biosynthetic process (GO:0006704) | 2.44446095 |
| 86 | alanine transport (GO:0032328) | 2.44300042 |
| 87 | regulation of synaptic plasticity (GO:0048167) | 2.43523814 |
| 88 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.42931651 |
| 89 | regulation of vesicle fusion (GO:0031338) | 2.42589697 |
| 90 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.42294362 |
| 91 | membrane depolarization during action potential (GO:0086010) | 2.42188673 |
| 92 | cGMP biosynthetic process (GO:0006182) | 2.41581063 |
| 93 | flavonoid metabolic process (GO:0009812) | 2.41464961 |
| 94 | establishment of nucleus localization (GO:0040023) | 2.39647811 |
| 95 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.39321518 |
| 96 | monovalent inorganic cation homeostasis (GO:0055067) | 2.39269284 |
| 97 | glucuronate metabolic process (GO:0019585) | 2.38949435 |
| 98 | uronic acid metabolic process (GO:0006063) | 2.38949435 |
| 99 | dendrite morphogenesis (GO:0048813) | 2.38868234 |
| 100 | sodium ion homeostasis (GO:0055078) | 2.38222447 |
| 101 | multicellular organismal water homeostasis (GO:0050891) | 2.38134263 |
| 102 | water transport (GO:0006833) | 2.37963270 |
| 103 | long-term synaptic potentiation (GO:0060291) | 2.35297464 |
| 104 | one-carbon compound transport (GO:0019755) | 2.34805049 |
| 105 | presynaptic membrane organization (GO:0097090) | 2.34637466 |
| 106 | labyrinthine layer development (GO:0060711) | 2.34410681 |
| 107 | positive regulation of membrane potential (GO:0045838) | 2.34099991 |
| 108 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.33791010 |
| 109 | layer formation in cerebral cortex (GO:0021819) | 2.33518114 |
| 110 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.31766763 |
| 111 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.30946185 |
| 112 | response to histamine (GO:0034776) | 2.30716873 |
| 113 | neuromuscular process controlling balance (GO:0050885) | 2.30395372 |
| 114 | astrocyte differentiation (GO:0048708) | 2.29926334 |
| 115 | regulation of cell communication by electrical coupling (GO:0010649) | 2.29219944 |
| 116 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.28870260 |
| 117 | regulation of postsynaptic membrane potential (GO:0060078) | 2.28517564 |
| 118 | negative regulation of protein localization to cell surface (GO:2000009) | 2.26783703 |
| 119 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.26768229 |
| 120 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.26424047 |
| 121 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.25924891 |
| 122 | long term synaptic depression (GO:0060292) | 2.25750426 |
| 123 | negative regulation of hormone metabolic process (GO:0032351) | 2.25426567 |
| 124 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.25426567 |
| 125 | oligosaccharide biosynthetic process (GO:0009312) | 2.25224384 |
| 126 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.24958535 |
| 127 | fluid transport (GO:0042044) | 2.24242226 |
| 128 | lipid translocation (GO:0034204) | 2.23570441 |
| 129 | phospholipid translocation (GO:0045332) | 2.23570441 |
| 130 | positive regulation of vesicle fusion (GO:0031340) | 2.23019412 |
| 131 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.23000645 |
| 132 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.22384507 |
| 133 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.21601793 |
| 134 | regulation of neurotransmitter levels (GO:0001505) | 2.21358352 |
| 135 | dendritic spine morphogenesis (GO:0060997) | 2.21202340 |
| 136 | membrane assembly (GO:0071709) | 2.20372925 |
| 137 | regulation of beta-amyloid formation (GO:1902003) | 2.20268765 |
| 138 | chloride transmembrane transport (GO:1902476) | 2.20118596 |
| 139 | sodium ion transmembrane transport (GO:0035725) | 2.20111339 |
| 140 | negative regulation of amino acid transport (GO:0051956) | 2.19662707 |
| 141 | membrane depolarization (GO:0051899) | 2.17964158 |
| 142 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.17894971 |
| 143 | relaxation of cardiac muscle (GO:0055119) | 2.17518303 |
| 144 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.17134353 |
| 145 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.16743937 |
| 146 | peripheral nervous system development (GO:0007422) | 2.16445154 |
| 147 | regulation of pseudopodium assembly (GO:0031272) | 2.16125589 |
| 148 | protein localization to endosome (GO:0036010) | 2.15923826 |
| 149 | response to auditory stimulus (GO:0010996) | 2.15759587 |
| 150 | cardiac conduction (GO:0061337) | 2.15412247 |
| 151 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.15392938 |
| 152 | endocrine process (GO:0050886) | 2.15278393 |
| 153 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.15278393 |
| 154 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.15278393 |
| 155 | excretion (GO:0007588) | 2.14990932 |
| 156 | inorganic anion transmembrane transport (GO:0098661) | 2.14784012 |
| 157 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.14189837 |
| 158 | auditory receptor cell differentiation (GO:0042491) | 2.14171554 |
| 159 | renal absorption (GO:0070293) | 2.13657050 |
| 160 | intestinal absorption (GO:0050892) | 2.09957047 |
| 161 | vesicle transport along microtubule (GO:0047496) | 2.08621961 |
| 162 | positive regulation of potassium ion transport (GO:0043268) | 2.05980481 |
| 163 | protein targeting to Golgi (GO:0000042) | 2.05792631 |
| 164 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.04908702 |
| 165 | transmission of nerve impulse (GO:0019226) | 2.04855087 |
| 166 | positive regulation of heat generation (GO:0031652) | 2.04032677 |
| 167 | inner ear receptor cell development (GO:0060119) | 2.03754601 |
| 168 | establishment of protein localization to Golgi (GO:0072600) | 2.02832601 |
| 169 | positive regulation of synapse maturation (GO:0090129) | 2.02805791 |
| 170 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.02421241 |
| 171 | filopodium assembly (GO:0046847) | 2.02388230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.36557449 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.47437235 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.39436503 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37279027 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.28098378 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.12202917 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.04866214 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.03973886 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03878662 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.01546034 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.01546034 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00723703 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.97854546 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.92463514 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83782824 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75950858 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75492275 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.73969751 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71498589 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.70791509 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.68853753 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.63537201 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62305913 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59529140 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55094682 |
| 26 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54062921 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.53690405 |
| 28 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50457675 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48545989 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.48453807 |
| 31 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.46109645 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44759824 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42715739 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40223441 |
| 35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.34054668 |
| 36 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32126179 |
| 37 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31161148 |
| 38 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30827195 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30503791 |
| 40 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30050036 |
| 41 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29919911 |
| 42 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23527189 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23184649 |
| 44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.20724353 |
| 45 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18783480 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18671091 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18174022 |
| 48 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17609851 |
| 49 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.15919210 |
| 50 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15723662 |
| 51 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15723662 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14869899 |
| 53 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13522786 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13144626 |
| 55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13016911 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12441083 |
| 57 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12046675 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11911800 |
| 59 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11863132 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11761496 |
| 61 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11126745 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10927727 |
| 63 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.10681076 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10160047 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08441102 |
| 66 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07780177 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07181907 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06762767 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06414275 |
| 70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06253916 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06057199 |
| 72 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06041693 |
| 73 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.04968457 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04942147 |
| 75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.04742006 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04474937 |
| 77 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04238885 |
| 78 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04002395 |
| 79 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03764250 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02507484 |
| 81 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.01850496 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01535891 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 1.00704592 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00122436 |
| 85 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98515813 |
| 86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97261916 |
| 87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96521057 |
| 88 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96446734 |
| 89 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.96344028 |
| 90 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.95694383 |
| 91 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95322543 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95171152 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94732357 |
| 94 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94503195 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93749131 |
| 96 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93413408 |
| 97 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93289253 |
| 98 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92890026 |
| 99 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92875040 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92555887 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91710828 |
| 102 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90910680 |
| 103 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90848099 |
| 104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90188379 |
| 105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89666687 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89440815 |
| 107 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87884430 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.86487636 |
| 109 | TCF4_23295773_ChIP-Seq_U87_Human | 0.86075914 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85714736 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84978482 |
| 112 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.84049594 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83955050 |
| 114 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83802640 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82936473 |
| 116 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81160863 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80901294 |
| 118 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80639501 |
| 119 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80290750 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80173318 |
| 121 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78749706 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78718681 |
| 123 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78507926 |
| 124 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.78034823 |
| 125 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.77957386 |
| 126 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.77491793 |
| 127 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.77352164 |
| 128 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.77210974 |
| 129 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76625563 |
| 130 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76384102 |
| 131 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.76202855 |
| 132 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.75317315 |
| 133 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.75198385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.51381641 |
| 2 | MP0002822_catalepsy | 3.56756280 |
| 3 | MP0002254_reproductive_system_inflammat | 3.02489613 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.00847995 |
| 5 | MP0004782_abnormal_surfactant_physiolog | 2.96902286 |
| 6 | MP0003880_abnormal_central_pattern | 2.83968046 |
| 7 | MP0004270_analgesia | 2.79316675 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.71014060 |
| 9 | MP0000566_synostosis | 2.70154124 |
| 10 | MP0004043_abnormal_pH_regulation | 2.57406235 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.55404718 |
| 12 | MP0009745_abnormal_behavioral_response | 2.54590271 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.47438649 |
| 14 | MP0005409_darkened_coat_color | 2.42592280 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.36179807 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.30678579 |
| 17 | MP0002064_seizures | 2.16864135 |
| 18 | MP0009379_abnormal_foot_pigmentation | 2.00360494 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 1.97426328 |
| 20 | MP0003879_abnormal_hair_cell | 1.95604833 |
| 21 | MP0002909_abnormal_adrenal_gland | 1.95051905 |
| 22 | MP0009046_muscle_twitch | 1.94230752 |
| 23 | MP0001765_abnormal_ion_homeostasis | 1.92527261 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.90380310 |
| 25 | MP0004858_abnormal_nervous_system | 1.90261994 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.87532503 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.85259110 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 1.84307685 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.81970422 |
| 30 | MP0002735_abnormal_chemical_nociception | 1.81146647 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.79042995 |
| 32 | MP0005310_abnormal_salivary_gland | 1.76718740 |
| 33 | MP0000579_abnormal_nail_morphology | 1.73155762 |
| 34 | MP0002272_abnormal_nervous_system | 1.71891848 |
| 35 | MP0008569_lethality_at_weaning | 1.69019476 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.68279086 |
| 37 | MP0001486_abnormal_startle_reflex | 1.67330753 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.64435246 |
| 39 | MP0003136_yellow_coat_color | 1.61482294 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.59158670 |
| 41 | MP0005248_abnormal_Harderian_gland | 1.58659163 |
| 42 | MP0003283_abnormal_digestive_organ | 1.57208768 |
| 43 | MP0003075_altered_response_to | 1.53915951 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.53498166 |
| 45 | MP0003868_abnormal_feces_composition | 1.52484496 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.47419697 |
| 47 | MP0010678_abnormal_skin_adnexa | 1.45606589 |
| 48 | MP0004885_abnormal_endolymph | 1.44479565 |
| 49 | MP0004510_myositis | 1.43833921 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.43369489 |
| 51 | MP0005171_absent_coat_pigmentation | 1.42345473 |
| 52 | MP0003866_abnormal_defecation | 1.41240689 |
| 53 | MP0003329_amyloid_beta_deposits | 1.40609777 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.39667903 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.38205792 |
| 56 | MP0003045_fibrosis | 1.37254748 |
| 57 | MP0003690_abnormal_glial_cell | 1.34901459 |
| 58 | MP0001873_stomach_inflammation | 1.33805645 |
| 59 | MP0001666_abnormal_nutrient_absorption | 1.32959171 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.32724104 |
| 61 | MP0001664_abnormal_digestion | 1.32323377 |
| 62 | MP0005423_abnormal_somatic_nervous | 1.32117573 |
| 63 | MP0005535_abnormal_body_temperature | 1.31296056 |
| 64 | MP0002736_abnormal_nociception_after | 1.30558287 |
| 65 | MP0003633_abnormal_nervous_system | 1.29902282 |
| 66 | MP0001970_abnormal_pain_threshold | 1.29052264 |
| 67 | MP0002638_abnormal_pupillary_reflex | 1.29010702 |
| 68 | MP0002067_abnormal_sensory_capabilities | 1.26955581 |
| 69 | MP0004147_increased_porphyrin_level | 1.25892922 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.25072681 |
| 71 | MP0000477_abnormal_intestine_morphology | 1.20756213 |
| 72 | MP0001958_emphysema | 1.20619623 |
| 73 | MP0000920_abnormal_myelination | 1.19652231 |
| 74 | MP0003705_abnormal_hypodermis_morpholog | 1.19534009 |
| 75 | MP0005360_urolithiasis | 1.17586810 |
| 76 | MP0001348_abnormal_lacrimal_gland | 1.14617586 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 1.14134587 |
| 78 | MP0003878_abnormal_ear_physiology | 1.13555203 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 1.13555203 |
| 80 | MP0004484_altered_response_of | 1.12346176 |
| 81 | MP0001177_atelectasis | 1.12270391 |
| 82 | MP0005365_abnormal_bile_salt | 1.10958679 |
| 83 | MP0009384_cardiac_valve_regurgitation | 1.07091355 |
| 84 | MP0002557_abnormal_social/conspecific_i | 1.06887954 |
| 85 | MP0000604_amyloidosis | 1.04205342 |
| 86 | MP0004130_abnormal_muscle_cell | 1.02370466 |
| 87 | MP0000762_abnormal_tongue_morphology | 1.02282483 |
| 88 | MP0001346_abnormal_lacrimal_gland | 1.01923979 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 1.01229454 |
| 90 | MP0000383_abnormal_hair_follicle | 1.00440419 |
| 91 | MP0003634_abnormal_glial_cell | 0.99219671 |
| 92 | MP0000537_abnormal_urethra_morphology | 0.99041783 |
| 93 | MP0001984_abnormal_olfaction | 0.98592781 |
| 94 | MP0002098_abnormal_vibrissa_morphology | 0.98427687 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.96924680 |
| 96 | MP0005166_decreased_susceptibility_to | 0.96874857 |
| 97 | MP0005388_respiratory_system_phenotype | 0.96619437 |
| 98 | MP0002133_abnormal_respiratory_system | 0.96619437 |
| 99 | MP0004019_abnormal_vitamin_homeostasis | 0.96163125 |
| 100 | MP0003632_abnormal_nervous_system | 0.95226769 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.93231452 |
| 102 | MP0004924_abnormal_behavior | 0.93231452 |
| 103 | MP0008872_abnormal_physiological_respon | 0.92611641 |
| 104 | MP0005670_abnormal_white_adipose | 0.91631078 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.91280425 |
| 106 | MP0000751_myopathy | 0.90661365 |
| 107 | MP0003631_nervous_system_phenotype | 0.87660696 |
| 108 | MP0001663_abnormal_digestive_system | 0.85872183 |
| 109 | MP0003011_delayed_dark_adaptation | 0.85812919 |
| 110 | MP0002066_abnormal_motor_capabilities/c | 0.85479784 |
| 111 | MP0004811_abnormal_neuron_physiology | 0.84591900 |
| 112 | MP0005448_abnormal_energy_balance | 0.84486636 |
| 113 | MP0000538_abnormal_urinary_bladder | 0.81979404 |
| 114 | MP0005646_abnormal_pituitary_gland | 0.81707691 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.80896466 |
| 116 | MP0002006_tumorigenesis | 0.80662591 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.80654858 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.80602654 |
| 119 | MP0000377_abnormal_hair_follicle | 0.80461249 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.79446542 |
| 121 | MP0001756_abnormal_urination | 0.78506555 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.76999011 |
| 123 | MP0003172_abnormal_lysosome_physiology | 0.76524429 |
| 124 | MP0001188_hyperpigmentation | 0.76250528 |
| 125 | MP0000462_abnormal_digestive_system | 0.75874733 |
| 126 | MP0005165_increased_susceptibility_to | 0.75114056 |
| 127 | MP0004215_abnormal_myocardial_fiber | 0.75022176 |
| 128 | MP0000747_muscle_weakness | 0.74662433 |
| 129 | MP0003091_abnormal_cell_migration | 0.74192673 |
| 130 | MP0005381_digestive/alimentary_phenotyp | 0.74100981 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.73222472 |
| 132 | MP0000026_abnormal_inner_ear | 0.73152852 |
| 133 | MP0005595_abnormal_vascular_smooth | 0.73074563 |
| 134 | MP0003787_abnormal_imprinting | 0.72591698 |
| 135 | MP0000778_abnormal_nervous_system | 0.72150441 |
| 136 | MP0000955_abnormal_spinal_cord | 0.72049801 |
| 137 | MP0002229_neurodegeneration | 0.71475777 |
| 138 | MP0002882_abnormal_neuron_morphology | 0.71371059 |
| 139 | MP0001485_abnormal_pinna_reflex | 0.70296654 |
| 140 | MP0008874_decreased_physiological_sensi | 0.69877776 |
| 141 | MP0010155_abnormal_intestine_physiology | 0.68843885 |
| 142 | MP0002136_abnormal_kidney_physiology | 0.67487303 |
| 143 | MP0005636_abnormal_mineral_homeostasis | 0.67096571 |
| 144 | MP0002971_abnormal_brown_adipose | 0.66859824 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.66688121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 5.41141666 |
| 2 | Focal motor seizures (HP:0011153) | 5.25856163 |
| 3 | Increased circulating renin level (HP:0000848) | 4.92841989 |
| 4 | Metabolic alkalosis (HP:0200114) | 4.73688743 |
| 5 | Myokymia (HP:0002411) | 4.31768697 |
| 6 | Flat acetabular roof (HP:0003180) | 4.00686388 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 3.94154073 |
| 8 | Abnormality of renin-angiotensin system (HP:0000847) | 3.85941865 |
| 9 | Decreased circulating renin level (HP:0003351) | 3.65403004 |
| 10 | Hyperaldosteronism (HP:0000859) | 3.64372664 |
| 11 | Focal seizures (HP:0007359) | 3.62123810 |
| 12 | Retinal atrophy (HP:0001105) | 3.52916049 |
| 13 | Visual hallucinations (HP:0002367) | 3.18130016 |
| 14 | Hypokalemic alkalosis (HP:0001949) | 3.12989050 |
| 15 | Hyponatremia (HP:0002902) | 3.11764142 |
| 16 | Hyperkalemia (HP:0002153) | 3.09989213 |
| 17 | Adrenal overactivity (HP:0002717) | 3.08814225 |
| 18 | Febrile seizures (HP:0002373) | 3.07086299 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.06388918 |
| 20 | Action tremor (HP:0002345) | 3.05096141 |
| 21 | Hypomagnesemia (HP:0002917) | 3.01376929 |
| 22 | Ventricular fibrillation (HP:0001663) | 3.00127046 |
| 23 | Supranuclear gaze palsy (HP:0000605) | 2.97606906 |
| 24 | Exercise-induced myalgia (HP:0003738) | 2.97103435 |
| 25 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.96209618 |
| 26 | Hydroxyprolinuria (HP:0003080) | 2.92048197 |
| 27 | Abnormality of proline metabolism (HP:0010907) | 2.92048197 |
| 28 | Epileptic encephalopathy (HP:0200134) | 2.86509617 |
| 29 | Abnormality of magnesium homeostasis (HP:0004921) | 2.83451029 |
| 30 | Neonatal short-limb short stature (HP:0008921) | 2.81742380 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.79855048 |
| 32 | Visceral angiomatosis (HP:0100761) | 2.72207478 |
| 33 | Abnormality of potassium homeostasis (HP:0011042) | 2.71774276 |
| 34 | Abnormality of renal excretion (HP:0011036) | 2.67363243 |
| 35 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.66433019 |
| 36 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.60075589 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.57390538 |
| 38 | Hyperphosphatemia (HP:0002905) | 2.57165564 |
| 39 | Hypercortisolism (HP:0001578) | 2.53255786 |
| 40 | Atonic seizures (HP:0010819) | 2.52091490 |
| 41 | Abnormal urine output (HP:0012590) | 2.51682431 |
| 42 | Hemangiomatosis (HP:0007461) | 2.50269257 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.48388401 |
| 44 | Postural instability (HP:0002172) | 2.45745235 |
| 45 | Dysmetria (HP:0001310) | 2.45739950 |
| 46 | Chronic bronchitis (HP:0004469) | 2.41974010 |
| 47 | Vertebral clefting (HP:0008428) | 2.39946911 |
| 48 | Gout (HP:0001997) | 2.39168838 |
| 49 | Polyuria (HP:0000103) | 2.37285578 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 2.36495353 |
| 51 | Pili torti (HP:0003777) | 2.36435198 |
| 52 | Absence seizures (HP:0002121) | 2.33300847 |
| 53 | Muscle fiber inclusion bodies (HP:0100299) | 2.32129893 |
| 54 | Cerebellar dysplasia (HP:0007033) | 2.32005567 |
| 55 | Hemiplegia (HP:0002301) | 2.30673708 |
| 56 | Generalized tonic-clonic seizures (HP:0002069) | 2.28068731 |
| 57 | Abnormality of the lower motor neuron (HP:0002366) | 2.27667880 |
| 58 | Dysdiadochokinesis (HP:0002075) | 2.27346334 |
| 59 | Hypokalemia (HP:0002900) | 2.26497297 |
| 60 | Abnormal drinking behavior (HP:0030082) | 2.25168316 |
| 61 | Polydipsia (HP:0001959) | 2.25168316 |
| 62 | Dialeptic seizures (HP:0011146) | 2.24025523 |
| 63 | Buphthalmos (HP:0000557) | 2.22394735 |
| 64 | Dysmetric saccades (HP:0000641) | 2.20893119 |
| 65 | Genetic anticipation (HP:0003743) | 2.18430939 |
| 66 | Renal salt wasting (HP:0000127) | 2.15640204 |
| 67 | Flattened epiphyses (HP:0003071) | 2.15211340 |
| 68 | Nemaline bodies (HP:0003798) | 2.14712766 |
| 69 | Tetany (HP:0001281) | 2.14295432 |
| 70 | Scanning speech (HP:0002168) | 2.13884001 |
| 71 | Hypoplasia of dental enamel (HP:0006297) | 2.11941331 |
| 72 | Alkalosis (HP:0001948) | 2.11639132 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 2.11009160 |
| 74 | Bundle branch block (HP:0011710) | 2.10965450 |
| 75 | Truncal ataxia (HP:0002078) | 2.08573306 |
| 76 | Intention tremor (HP:0002080) | 2.08060742 |
| 77 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.07844757 |
| 78 | Hyperparathyroidism (HP:0000843) | 2.07332635 |
| 79 | Exercise-induced muscle cramps (HP:0003710) | 2.07100922 |
| 80 | Hemiparesis (HP:0001269) | 2.06475044 |
| 81 | Impaired smooth pursuit (HP:0007772) | 1.99928770 |
| 82 | Ileus (HP:0002595) | 1.97109181 |
| 83 | Split foot (HP:0001839) | 1.96501407 |
| 84 | Depression (HP:0000716) | 1.94258880 |
| 85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93674195 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 1.93541238 |
| 87 | Bronchomalacia (HP:0002780) | 1.91544077 |
| 88 | Amelogenesis imperfecta (HP:0000705) | 1.90381146 |
| 89 | Chronic diarrhea (HP:0002028) | 1.90349649 |
| 90 | Hypotension (HP:0002615) | 1.89985722 |
| 91 | Syncope (HP:0001279) | 1.89807473 |
| 92 | Difficulty climbing stairs (HP:0003551) | 1.88856085 |
| 93 | Increased purine levels (HP:0004368) | 1.88636707 |
| 94 | Hyperuricemia (HP:0002149) | 1.88636707 |
| 95 | Impaired social interactions (HP:0000735) | 1.87953680 |
| 96 | Abnormal social behavior (HP:0012433) | 1.87953680 |
| 97 | Muscle stiffness (HP:0003552) | 1.86255736 |
| 98 | Neurofibrillary tangles (HP:0002185) | 1.85603770 |
| 99 | Akinesia (HP:0002304) | 1.85537118 |
| 100 | Abdominal distention (HP:0003270) | 1.85020516 |
| 101 | Prolonged QT interval (HP:0001657) | 1.84331931 |
| 102 | Focal segmental glomerulosclerosis (HP:0000097) | 1.83373677 |
| 103 | Ankle clonus (HP:0011448) | 1.83142311 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 1.81839016 |
| 105 | Spinal cord compression (HP:0002176) | 1.80862474 |
| 106 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80541760 |
| 107 | Broad-based gait (HP:0002136) | 1.80345658 |
| 108 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.80310452 |
| 109 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.80219232 |
| 110 | Aplasia of the phalanges of the hand (HP:0009802) | 1.80219232 |
| 111 | Aplasia involving bones of the extremities (HP:0009825) | 1.80219232 |
| 112 | Symptomatic seizures (HP:0011145) | 1.80164959 |
| 113 | Mucopolysacchariduria (HP:0008155) | 1.79254275 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79254275 |
| 115 | Difficulty running (HP:0009046) | 1.79091947 |
| 116 | Dehydration (HP:0001944) | 1.79087231 |
| 117 | Partial duplication of thumb phalanx (HP:0009944) | 1.78440340 |
| 118 | Increased IgE level (HP:0003212) | 1.77588882 |
| 119 | Amyotrophic lateral sclerosis (HP:0007354) | 1.77471708 |
| 120 | Papilledema (HP:0001085) | 1.77236076 |
| 121 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77114433 |
| 122 | Interstitial pulmonary disease (HP:0006530) | 1.76459449 |
| 123 | Widely patent fontanelles and sutures (HP:0004492) | 1.75737251 |
| 124 | Confusion (HP:0001289) | 1.75568082 |
| 125 | Anxiety (HP:0000739) | 1.75412662 |
| 126 | Right ventricular cardiomyopathy (HP:0011663) | 1.75383838 |
| 127 | Cone-rod dystrophy (HP:0000548) | 1.74576247 |
| 128 | Hypercalciuria (HP:0002150) | 1.73845483 |
| 129 | Stereotypic behavior (HP:0000733) | 1.73642359 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73466765 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73466765 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73466765 |
| 133 | Urinary urgency (HP:0000012) | 1.72831639 |
| 134 | Spastic tetraparesis (HP:0001285) | 1.72788799 |
| 135 | Abnormal cartilage morphology (HP:0002763) | 1.71428198 |
| 136 | Excessive salivation (HP:0003781) | 1.71018326 |
| 137 | Drooling (HP:0002307) | 1.71018326 |
| 138 | Intrahepatic cholestasis (HP:0001406) | 1.70439713 |
| 139 | Dysostosis multiplex (HP:0000943) | 1.69693650 |
| 140 | Abnormality of sodium homeostasis (HP:0010931) | 1.69182555 |
| 141 | Abnormality of the gastric mucosa (HP:0004295) | 1.68422031 |
| 142 | Thickened helices (HP:0000391) | 1.67970091 |
| 143 | Hip contracture (HP:0003273) | 1.67301883 |
| 144 | Breech presentation (HP:0001623) | 1.66349257 |
| 145 | Conjugated hyperbilirubinemia (HP:0002908) | 1.66207441 |
| 146 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.65879234 |
| 147 | Rapidly progressive (HP:0003678) | 1.64230177 |
| 148 | Flat capital femoral epiphysis (HP:0003370) | 1.63900067 |
| 149 | Vertebral hypoplasia (HP:0008417) | 1.62920061 |
| 150 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.62920061 |
| 151 | Diplopia (HP:0000651) | 1.62580870 |
| 152 | Abnormality of binocular vision (HP:0011514) | 1.62580870 |
| 153 | Heart block (HP:0012722) | 1.61240346 |
| 154 | Hemorrhage of the eye (HP:0011885) | 1.61192058 |
| 155 | Large earlobe (HP:0009748) | 1.59800427 |
| 156 | Type II lissencephaly (HP:0007260) | 1.59053879 |
| 157 | Limited hip movement (HP:0008800) | 1.56818659 |
| 158 | Congenital glaucoma (HP:0001087) | 1.55138204 |
| 159 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.54251623 |
| 160 | Type 1 muscle fiber predominance (HP:0003803) | 1.53340720 |
| 161 | Abnormality of the dental root (HP:0006486) | 1.51523770 |
| 162 | Taurodontia (HP:0000679) | 1.51523770 |
| 163 | Abnormality of permanent molar morphology (HP:0011071) | 1.51523770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.62085668 |
| 2 | PIK3CA | 3.25079908 |
| 3 | EPHA4 | 3.21096215 |
| 4 | LMTK2 | 2.86840623 |
| 5 | MAP3K9 | 2.77025148 |
| 6 | TNIK | 2.32844548 |
| 7 | MAP3K2 | 2.30057248 |
| 8 | FRK | 2.22460022 |
| 9 | MET | 2.17140699 |
| 10 | EPHB2 | 2.07275616 |
| 11 | OBSCN | 2.06053182 |
| 12 | EPHA2 | 2.03907471 |
| 13 | CASK | 2.01413824 |
| 14 | WNK4 | 1.90960829 |
| 15 | PRKD3 | 1.88753414 |
| 16 | MAP3K4 | 1.86493425 |
| 17 | KSR2 | 1.83210682 |
| 18 | PDK2 | 1.82954635 |
| 19 | RIPK4 | 1.79601532 |
| 20 | MAP3K13 | 1.78739760 |
| 21 | RIPK1 | 1.77136282 |
| 22 | ACVR1B | 1.76374362 |
| 23 | DAPK2 | 1.72403495 |
| 24 | MST1R | 1.71195005 |
| 25 | OXSR1 | 1.60656799 |
| 26 | NEK6 | 1.59719952 |
| 27 | CAMKK1 | 1.55104902 |
| 28 | MAP3K7 | 1.50254517 |
| 29 | STK38 | 1.49843948 |
| 30 | WNK3 | 1.49128899 |
| 31 | MAP3K14 | 1.45606547 |
| 32 | NTRK2 | 1.42568699 |
| 33 | STK24 | 1.35937689 |
| 34 | MINK1 | 1.31354695 |
| 35 | MAP2K7 | 1.28303581 |
| 36 | FGFR4 | 1.27533029 |
| 37 | FGFR2 | 1.25715757 |
| 38 | WNK1 | 1.23928504 |
| 39 | SGK3 | 1.14998082 |
| 40 | PAK6 | 1.14633519 |
| 41 | CDK5 | 1.14470516 |
| 42 | FER | 1.12538593 |
| 43 | STK39 | 1.09956456 |
| 44 | MARK3 | 1.08278326 |
| 45 | FES | 1.08035919 |
| 46 | MAP3K1 | 1.07591275 |
| 47 | CAMKK2 | 1.02782279 |
| 48 | SGK2 | 1.02759885 |
| 49 | BCR | 1.02429867 |
| 50 | JAK1 | 1.01897896 |
| 51 | FGFR3 | 1.00743330 |
| 52 | PDK1 | 1.00092095 |
| 53 | NTRK1 | 0.96219799 |
| 54 | MAP2K4 | 0.95790687 |
| 55 | PDPK1 | 0.95737130 |
| 56 | SGK223 | 0.95713094 |
| 57 | SGK494 | 0.95713094 |
| 58 | EEF2K | 0.94916962 |
| 59 | NME1 | 0.94485348 |
| 60 | MARK2 | 0.91901135 |
| 61 | ERBB2 | 0.91883077 |
| 62 | EPHB1 | 0.91156442 |
| 63 | PDGFRA | 0.90873169 |
| 64 | NLK | 0.90630966 |
| 65 | UHMK1 | 0.90586162 |
| 66 | RET | 0.89981350 |
| 67 | TAOK1 | 0.89933847 |
| 68 | PRKCH | 0.89874442 |
| 69 | SGK1 | 0.89476462 |
| 70 | INSRR | 0.87806955 |
| 71 | CAMK1 | 0.87737644 |
| 72 | STK11 | 0.87204129 |
| 73 | PRPF4B | 0.86887346 |
| 74 | KSR1 | 0.85189562 |
| 75 | ICK | 0.84335541 |
| 76 | MAP3K12 | 0.84077979 |
| 77 | CDC42BPA | 0.83602301 |
| 78 | CAMK1G | 0.81004169 |
| 79 | DYRK1A | 0.79077393 |
| 80 | PTK6 | 0.78569779 |
| 81 | LATS2 | 0.78375459 |
| 82 | MARK1 | 0.77744972 |
| 83 | MAPK12 | 0.77606086 |
| 84 | STK10 | 0.76553768 |
| 85 | YES1 | 0.74354955 |
| 86 | BMX | 0.73397872 |
| 87 | CAMK2B | 0.73305804 |
| 88 | PRKAA2 | 0.72657713 |
| 89 | GRK5 | 0.72611521 |
| 90 | MST4 | 0.71939619 |
| 91 | JAK2 | 0.71272091 |
| 92 | PRKG2 | 0.70706235 |
| 93 | IRAK3 | 0.69473561 |
| 94 | STK38L | 0.68087762 |
| 95 | TYRO3 | 0.67344082 |
| 96 | CAMK1D | 0.66367954 |
| 97 | MAPK7 | 0.64354179 |
| 98 | EPHA3 | 0.63929418 |
| 99 | MAP2K2 | 0.61322385 |
| 100 | CAMK2A | 0.60399583 |
| 101 | DMPK | 0.59656507 |
| 102 | DAPK1 | 0.59445271 |
| 103 | MAP3K10 | 0.58467613 |
| 104 | DDR2 | 0.56495789 |
| 105 | RPS6KA2 | 0.56217725 |
| 106 | MAPK15 | 0.55973611 |
| 107 | SIK2 | 0.55351454 |
| 108 | TBK1 | 0.54036800 |
| 109 | TTN | 0.53658881 |
| 110 | PTK2B | 0.50616594 |
| 111 | PTK2 | 0.49889236 |
| 112 | MAP2K1 | 0.49660548 |
| 113 | MAP3K6 | 0.49623557 |
| 114 | SCYL2 | 0.49534374 |
| 115 | PRKCG | 0.49299415 |
| 116 | JAK3 | 0.48650362 |
| 117 | FYN | 0.46975647 |
| 118 | ALK | 0.45995508 |
| 119 | PRKCZ | 0.45993500 |
| 120 | IKBKE | 0.45670589 |
| 121 | CDK6 | 0.45432869 |
| 122 | ERBB3 | 0.44988912 |
| 123 | PRKCE | 0.44065575 |
| 124 | RPS6KA3 | 0.42478391 |
| 125 | CAMK2G | 0.42432274 |
| 126 | ARAF | 0.42301253 |
| 127 | PRKAA1 | 0.41926894 |
| 128 | PHKG2 | 0.40945764 |
| 129 | PHKG1 | 0.40945764 |
| 130 | TRIB3 | 0.40600156 |
| 131 | PRKACG | 0.40491331 |
| 132 | PAK3 | 0.40135723 |
| 133 | ROCK2 | 0.40132323 |
| 134 | PDGFRB | 0.39892074 |
| 135 | CAMK2D | 0.39881606 |
| 136 | LRRK2 | 0.39752478 |
| 137 | SRC | 0.39014472 |
| 138 | MAPK13 | 0.38967870 |
| 139 | PRKCQ | 0.38788124 |
| 140 | PINK1 | 0.38280767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.34750657 |
| 2 | Histidine metabolism_Homo sapiens_hsa00340 | 2.34231063 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.33789221 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07817889 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 1.94741931 |
| 6 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.94404641 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92703134 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 1.88997245 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 1.84407024 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.84072696 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.83563837 |
| 12 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82471068 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81905994 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81109540 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69175887 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.68518486 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.66754678 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.63074357 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.59908625 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.56069035 |
| 21 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.44575916 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44033107 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.42850417 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.39229511 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37867795 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35663929 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.33270174 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31111521 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.27908387 |
| 30 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.25977986 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25776718 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22597230 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.22502982 |
| 34 | Tight junction_Homo sapiens_hsa04530 | 1.21859687 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19188478 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16374003 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.15995986 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.14600668 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12417180 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.11461425 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09588867 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09334827 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.07804802 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07706763 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07166052 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03993426 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03552493 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00393588 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00234490 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98444898 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95678320 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95642976 |
| 53 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.94368383 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94310792 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93369098 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91025444 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90427521 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88595170 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87953913 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87781121 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86393587 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85576189 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.84504307 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83227509 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82285944 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81869701 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81580171 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79601518 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78593449 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78111389 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78107391 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78019845 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76965728 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74759797 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74462111 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74125356 |
| 77 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73042701 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71863523 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71006367 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70287099 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68765576 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68516856 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68217795 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67278634 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67195202 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.65877706 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65645192 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65031744 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64196323 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.63302769 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63184162 |
| 92 | Gap junction_Homo sapiens_hsa04540 | 0.61884163 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61372255 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60727784 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58731789 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56865377 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56858016 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54183816 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53186268 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52529718 |
| 101 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52480613 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52424444 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52316983 |
| 104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51431354 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.50749492 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50060213 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49790151 |
| 108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49648713 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49545291 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49455083 |
| 111 | Melanogenesis_Homo sapiens_hsa04916 | 0.48873441 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48520266 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47901881 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47370268 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46784757 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46762113 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45669310 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45502993 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45499374 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45321833 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44216099 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.44102058 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43154192 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.42738850 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.42127209 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40134281 |
| 127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40127580 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39860073 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.39790355 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39564047 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.39244314 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38180696 |
| 133 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37618316 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37433955 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35969657 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35969519 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35387722 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34890732 |
| 139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34805861 |

